National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C10AA05	TULIP	G	Atorvastatin (calcium) - 20mg	20mg	Tablet, film coated	1,263,212 L.L
C09CA03	TABUVAN	G	Valsartan - 80mg	80mg	Tablet, film coated	387,027 L.L
G04BE08	TADALAGEN	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,766,193 L.L
G04BE08	TADILAS	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,583,046 L.L
G04BE08	TALYS	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,574,216 L.L
G04BE08	TYRA	G	Tadalafil - 5mg	5mg	Tablet, film coated	3,566,558 L.L
C09CA03	TABUVAN	G	Valsartan - 160mg	160mg	Tablet, film coated	544,256 L.L
J01MA12	TAVAQUIN 500MG	G	Levofloxacin - 500mg	500mg	Tablet, film coated	787,492 L.L
J01MA12	TAVANIC	B	Levofloxacin - 500mg	500mg	Tablet, film-scored	1,150,329 L.L
J01AA02	TOLEXINE	G	Doxycycline (monohydrate) - 100mg	100mg	Tablet, microgranules	589,947 L.L
C08DA51	TARKA	B	Verapamil - 240mg, Trandolapril - 4mg		Tablet, modified release	3,797,532 L.L
N02AX02	TRAMAL RETARD	B	Tramadol HCl - 100mg	100mg	Tablet, modified release	236,516 L.L
N02AX02	TRAMAL RETARD	B	Tramadol HCl - 150mg	150mg	Tablet, modified release	356,118 L.L
N02AX02	TRAMAL RETARD	B	Tramadol HCl - 200mg	200mg	Tablet, modified release	474,376 L.L
D01BA02	TERAFAN	G	Terbinafine HCl - 250mg	250mg	Tablet, scored	725,675 L.L
N05BA12	TRANQUINAL 0.5 SUBLINGUAL	G	Alprazolam - 0.5mg	0.5mg	Tablet, sublingual	459,594 L.L
N06AA02	TOFRANIL 10	B	Imipramine HCl - 10mg	10mg	Tablet, sugar coated	579,772 L.L
N06AA02	TOFRANIL 25	B	Imipramine HCl - 25mg	25mg	Tablet, sugar coated	1,002,123 L.L

National Cancer Registry (NCR)